Summary of combined results available for presentation to patients and clinicians
Following the announcement of EUPROMS 2.0 results at the European Association of Urology Congress in March, Europa Uomo has published an updated PowerPoint presentation providing an accessible overview of the combined research findings. The presentation, in English, is designed to inform men with prostate cancer, clinicians and decision-makers about the way treatments affect quality of life.
EUPROMS (Europa Uomo Patient Reported Outcome Study) is the first ever prostate cancer quality of life research conducted by patients for patients, exploring experiences of treatment and life afterwards. An initial EUPROMS 1.0 online survey of 3,000 men with prostate cancer was followed up with another in 2022, resulting in around 5,500 unique responses.
The combined findings of EUPROMS 1.0 and EUPROMS 1.0 show that:
- Men who had received prostatectomy and radiotherapy both experienced a significant reduction in sexual-function-related quality of life – with scores three times lower than those on active surveillance
- 20% of men had good erections after prostatectomy or radiotherapy treatment, compared with 58% on active surveillance
- 47% of men treated with prostatectomy had to use at least one incontinence pad a day after treatment
Versions of the PowerPoint in other European languages are currently in preparation.